1+ week, 5+ day ago   (293+ words) GLP-1 medicines are no longer just diabetes drugs. They are now reshaping obesity treatment, and a new review shows how quickly the field is moving. Researchers reviewed 38 randomised controlled trials involving more than 25,000 adults with overweight or obesity who did…...

1+ week, 5+ day ago   (288+ words) Concerns about GLP-1 medicines and mental health have been circulating for several years. A new review suggests the strongest evidence does not support a link with major psychiatric harm. They looked at claims that GLP-1 receptor agonists may increase suicidal…...

1+ mon, 21+ hour ago   (364+ words) A new oral GLP-1 medicine has shown strong weight loss results in a phase 2 trial. The drug, called aleniglipron, is being developed as a once-daily tablet for people with obesity or overweight. After 36 weeks, people taking the highest dose lost…...

1+ mon, 2+ week ago   (285+ words) GLP-1 drugs are best known for reducing appetite and supporting blood glucose control. New research suggests some oral GLP-1 drugs may also affect the reward side of eating. That matters because hunger and craving are not the same thing. A…...

2+ mon, 6+ day ago   (293+ words) Intermittent fasting may help people lose weight without the constant mental load of counting calories every day. A new trial from the University of Adelaide compared intermittent fasting with continuous calorie restriction and standard care. More than 200 adults with obesity…...

2+ mon, 4+ day ago   (938+ words) A tablet version of Wegovy has launched privately in the UK, giving people another way to access semaglutide-based weight loss treatment. The pill is taken once a day and is the first oral GLP-1 weight loss medicine approved in the…...

2+ mon, 5+ day ago   (580+ words) As temperatures rise across the UK, health professionals are warning that people taking GLP-1 medicines for weight loss or type 2 diabetes should be alert to the risk of dehydration. GLP-1 based treatments can help people feel fuller, reduce hunger and…...

2+ mon, 2+ week ago   (333+ words) GLP-1 drugs have changed obesity and type 2 diabetes treatment, but they are also creating new risks. A study in JAMA Psychiatry suggests people with eating disorders may be using and misusing these medicines at much higher rates than the general…...

2+ mon, 3+ week ago   (356+ words) GLP-1 drugs were developed for type 2 diabetes and then transformed weight loss treatment. Now they are raising another question. Could the same drugs also help reduce addictive behaviours? Human studies suggest GLP-1 agonists may reduce alcohol consumption. Animal studies suggest…...